These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


135 related items for PubMed ID: 17660454

  • 1. Nonsteroidal antiinflammatory drug use and breast cancer risk: subgroup findings.
    Kirsh VA, Kreiger N, Cotterchio M, Sloan M, Theis B.
    Am J Epidemiol; 2007 Sep 15; 166(6):709-16. PubMed ID: 17660454
    [Abstract] [Full Text] [Related]

  • 2. Alcohol and breast cancer risk defined by estrogen and progesterone receptor status: a case-control study.
    Deandrea S, Talamini R, Foschi R, Montella M, Dal Maso L, Falcini F, La Vecchia C, Franceschi S, Negri E.
    Cancer Epidemiol Biomarkers Prev; 2008 Aug 15; 17(8):2025-8. PubMed ID: 18708394
    [Abstract] [Full Text] [Related]

  • 3. Use of nonsteroidal antiinflammatory drugs and risk of breast cancer: the Case-Control Surveillance Study revisited.
    Zhang Y, Coogan PF, Palmer JR, Strom BL, Rosenberg L.
    Am J Epidemiol; 2005 Jul 15; 162(2):165-70. PubMed ID: 15972932
    [Abstract] [Full Text] [Related]

  • 4. Nonsteroidal anti-inflammatory drug use and breast cancer risk.
    Cotterchio M, Kreiger N, Sloan M, Steingart A.
    Cancer Epidemiol Biomarkers Prev; 2001 Nov 15; 10(11):1213-7. PubMed ID: 11700271
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Breast cancer risk factors according to joint estrogen receptor and progesterone receptor status.
    Rusiecki JA, Holford TR, Zahm SH, Zheng T.
    Cancer Detect Prev; 2005 Nov 15; 29(5):419-26. PubMed ID: 16185815
    [Abstract] [Full Text] [Related]

  • 7. Aspirin and other nonsteroidal anti-inflammatory drugs and breast cancer incidence in a large U.S. cohort.
    Jacobs EJ, Thun MJ, Connell CJ, Rodriguez C, Henley SJ, Feigelson HS, Patel AV, Flanders WD, Calle EE.
    Cancer Epidemiol Biomarkers Prev; 2005 Jan 15; 14(1):261-4. PubMed ID: 15668504
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Estrogen receptor-negative breast cancer is less likely to arise among lipophilic statin users.
    Kumar AS, Benz CC, Shim V, Minami CA, Moore DH, Esserman LJ.
    Cancer Epidemiol Biomarkers Prev; 2008 May 15; 17(5):1028-33. PubMed ID: 18463402
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The relationship of nonsteroidal anti-inflammatory drug use to the risk of breast cancer.
    Coogan PF, Rao SR, Rosenberg L, Palmer JR, Strom BL, Zauber AG, Stolley PD, Shapiro S.
    Prev Med; 1999 Aug 15; 29(2):72-6. PubMed ID: 10446030
    [Abstract] [Full Text] [Related]

  • 12. Nonsteroidal antiinflammatory drugs and breast cancer risk: the multiethnic cohort.
    Gill JK, Maskarinec G, Wilkens LR, Pike MC, Henderson BE, Kolonel LN.
    Am J Epidemiol; 2007 Nov 15; 166(10):1150-8. PubMed ID: 17698973
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Breast cancer and nonsteroidal anti-inflammatory drugs: prospective results from the Women's Health Initiative.
    Harris RE, Chlebowski RT, Jackson RD, Frid DJ, Ascenseo JL, Anderson G, Loar A, Rodabough RJ, White E, McTiernan A, Women's Health Initiative.
    Cancer Res; 2003 Sep 15; 63(18):6096-101. PubMed ID: 14522941
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Nonsteroidal anti-inflammatory drugs and risk of digestive cancers at sites other than the large bowel.
    Coogan PF, Rosenberg L, Palmer JR, Strom BL, Zauber AG, Stolley PD, Shapiro S.
    Cancer Epidemiol Biomarkers Prev; 2000 Jan 15; 9(1):119-23. PubMed ID: 10667472
    [Abstract] [Full Text] [Related]

  • 18. Reproductive factors and breast cancer risk according to joint estrogen and progesterone receptor status: a meta-analysis of epidemiological studies.
    Ma H, Bernstein L, Pike MC, Ursin G.
    Breast Cancer Res; 2006 Jan 15; 8(4):R43. PubMed ID: 16859501
    [Abstract] [Full Text] [Related]

  • 19. Nonsteroidal anti-inflammatory drug use and breast cancer risk: a Danish cohort study.
    Friis S, Thomassen L, Sørensen HT, Tjønneland A, Overvad K, Cronin-Fenton DP, Vogel U, McLaughlin JK, Blot WJ, Olsen JH.
    Eur J Cancer Prev; 2008 Apr 15; 17(2):88-96. PubMed ID: 18287865
    [Abstract] [Full Text] [Related]

  • 20. Breast cancer and use of nonsteroidal anti-inflammatory drugs: a meta-analysis.
    Takkouche B, Regueira-Méndez C, Etminan M.
    J Natl Cancer Inst; 2008 Oct 15; 100(20):1439-47. PubMed ID: 18840819
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.